BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ladino M, Pedraza F, Roth D. Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease. World J Hepatol 2017; 9(19): 833-839 [PMID: 28740594 DOI: 10.4254/wjh.v9.i19.833]
URL: https://www.wjgnet.com/1948-5182/full/v9/i19/833.htm
Number Citing Articles
1
Zana Sidiq Mohammed Saleem, Ibrahim A Naqid, Nawfal R Hussein, Sidra Jalal Mohammad, Jajeen Shaaban Noaman, Rajeen Salih Haji, Vin Ahmed Haji, Zainnab Muhsin Hussein, Piran Hussamaldin Mohammed. The Prevalence of Hepatitis B and C Virus in Patients With End-Stage Kidney Disease on Regular Hemodialysis in Duhok, Iraq: A Brief ReportAvicenna Journal of Clinical Microbiology and Infection 2020; 7(1): 31 doi: 10.34172/ajcmi.2020.06
2
Fernanda Bellini Lunardi MICHELS, Ana Cristina de Castro AMARAL, Roberto José de CARVALHO-FILHO, Gustavo de Almeida VIEIRA, Ana Lucia da Silva SOUZA, Maria Lucia Gomes FERRAZ. HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIRArquivos de Gastroenterologia 2020; 57(1): 45 doi: 10.1590/s0004-2803.202000000-09
3
Wei Liu, Xiwen Jiang, Yue Liu, Qingsong Ma. Bioinformatics Analysis of Quantitative PCR and Reverse Transcription PCR in Detecting HCV RNACurrent Bioinformatics 2019; 14(5): 400 doi: 10.2174/1574893613666180703103328
4
Marco Ladino, David Roth. Hepatitis C Virus Infection in ESKD PatientsClinical Journal of the American Society of Nephrology 2018; 13(11): 1735 doi: 10.2215/CJN.03700318
5
Javier Pagan, Marco Ladino, David Roth. Treating hepatitis C virus in dialysis patients: How, when, and why?Seminars in Dialysis 2019; 32(2): 152 doi: 10.1111/sdi.12764
6
Adriana Dejman, Marco A. Ladino, David Roth. Treatment and management options for the hepatitis C virus infected kidney transplant candidateHemodialysis International 2018; 22: S36 doi: 10.1111/hdi.12646
7
Yi-Chun Chen, Chung-Yi Li, Shiang-Jiun Tsai, Yen-Chun Chen. Anti-hepatitis C virus therapy in chronic kidney disease patients improves long-term renal and patient survivalsWorld Journal of Clinical Cases 2019; 7(11): 1270-1281 doi: 10.12998/wjcc.v7.i11.1270
8
Chen-Hua Liu, Chi-Yi Chen, Wei-Wen Su, Kuo-Chih Tseng, Ching-Chu Lo, Chun-Jen Liu, Jyh-Jou Chen, Cheng-Yuan Peng, Yu-Lueng Shih, Sheng-Shun Yang, Chia-Sheng Huang, Ke-Jhang Huang, Chi-Yang Chang, Ming-Chang Tsai, Wei-Yu Kao, Yo-Jen Fang, Po-Yueh Chen, Pei-Yuan Su, Chih-Wei Tseng, Jow-Jyh Huang, Pei-Lun Lee, Hsueh-Chou Lai, Tsai-Yuan Hsieh, Chung-Hsin Chang, Yi-Jie Huang, Fu-Jen Lee, Chun-Chao Chang, Jia-Horng Kao. Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentGut 2021; : gutjnl-2020-323569 doi: 10.1136/gutjnl-2020-323569